A theoretical basis for a biopharmaceutic drug classification : the correlation of in vitro drug product dissolution and in vivo bioavailability, Pharmaceutical Research, vol.12, issue.3, pp.413-420, 1995. ,
DOI : 10.1023/A:1016212804288
Mucoadhesive polymeric platforms for controlled drug delivery, European Journal of Pharmaceutics and Biopharmaceutics, vol.71, issue.3, 2009. ,
DOI : 10.1016/j.ejpb.2008.09.028
Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells, Biochemical and Biophysical Research Communications, vol.175, issue.3, pp.880-885, 1991. ,
DOI : 10.1016/0006-291X(91)91647-U
RITA ??? Registry of Industrial Toxicology Animal-data, Experimental and Toxicologic Pathology, vol.47, issue.4, pp.247-66, 1995. ,
DOI : 10.1016/S0940-2993(11)80259-9
Cell culture-based models for intestinal permeability: A critique, Drug Discovery Today, vol.10, issue.5, pp.335-4310, 2005. ,
DOI : 10.1016/S1359-6446(04)03354-9
A Short Review on Gastro Retentive Formulations for Stomach Specific Drug Delivery : Special Emphasis on Floating In situ Gel Systems, African J. Basic Appl. Sci, vol.3, pp.300-312, 2011. ,
The biopharmaceutics classification system (BCS): Class III drugs ??? better candidates for BA/BE waiver?, European Journal of Pharmaceutical Sciences, vol.9, issue.2, pp.117-121, 1999. ,
DOI : 10.1016/S0928-0987(99)00076-7
Engineered Magnetic Nanoparticles for Biomedical Applications, Advanced Healthcare Materials, vol.24, issue.2, pp.160-175, 2014. ,
DOI : 10.1002/adhm.201300141
Oral particulate delivery: status and future trends, Advanced Drug Delivery Reviews, vol.34, issue.2-3, pp.339-350, 1998. ,
DOI : 10.1016/S0169-409X(98)00047-7
Magnetically-responsive polymerized liposomes as potential oral delivery vehicles, Pharmaceutical Research, vol.14, issue.4, pp.537-540, 1997. ,
DOI : 10.1023/A:1012124205524
Magnetically Responsive Polymeric Microparticles for Oral Delivery of Protein Drugs, Pharmaceutical Research, vol.142, issue.3, pp.557-564, 2006. ,
DOI : 10.1007/s11095-005-9444-5
Planar Microdevices for Enhanced In Vivo Retention and Oral Bioavailability of Poorly Permeable Drugs, Advanced Healthcare Materials, vol.44, issue.10, pp.1648-54, 2014. ,
DOI : 10.1002/adhm.201300676
Formulation strategies for absorption windows, Drug Discovery Today, vol.10, issue.4, pp.249-257, 2005. ,
DOI : 10.1016/S1359-6446(04)03351-3
Gastrointestinal mucoadhesive patch system (GI-MAPS) for oral administration of G-CSF, a model protein, Biomaterials, vol.23, issue.1, pp.145-52, 2002. ,
DOI : 10.1016/S0142-9612(01)00089-8
In vitro and in vivo models for the study of oral delivery of nanoparticles, Advanced Drug Delivery Reviews, vol.65, issue.6, 2013. ,
DOI : 10.1016/j.addr.2013.01.003
Acyclovir serum concentrations following peroral administration of magnetic depot tablets and the influence of extracorporal magnets to control gastrointestinal transit, European Journal of Pharmaceutics and Biopharmaceutics, vol.46, issue.3, pp.285-291, 1998. ,
DOI : 10.1016/S0939-6411(98)00052-6
Magnetically modulated therapeutic systems, International Journal of Pharmaceutics, vol.277, issue.1-2, pp.19-24, 2004. ,
DOI : 10.1016/j.ijpharm.2003.03.002
Chitosan/calcium???alginate beads for oral delivery of insulin, 11<1795::AID-APP16>3.3.CO, pp.1795-1801, 1996. ,
DOI : 10.1002/(SICI)1097-4628(19960314)59:11<1795::AID-APP16>3.3.CO;2-F
The use of bioadhesives in targeted delivery within the gastrointestinal tract, Advanced Drug Delivery Reviews, vol.11, issue.3, pp.221-25110, 1993. ,
DOI : 10.1016/0169-409X(93)90011-R
Magnetic granules: a novel system for specific drug delivery to esophageal mucosa in oral administration, International Journal of Pharmaceutics, vol.61, issue.1-2, pp.109-117, 1990. ,
DOI : 10.1016/0378-5173(90)90049-A
Localization of magnetic pills, Proceedings of the National Academy of Sciences, vol.108, issue.6, pp.2252-2257, 2011. ,
DOI : 10.1073/pnas.1016367108
Understanding gastric forces calculated from high-resolution pill tracking, Proceedings of the National Academy of Sciences, vol.107, issue.18, pp.8201-8206, 2010. ,
DOI : 10.1073/pnas.1002292107
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2889561
Long term in vivo biotransformation of iron oxide nanoparticles, Biomaterials, vol.32, issue.16, pp.3988-99, 2011. ,
DOI : 10.1016/j.biomaterials.2011.02.031
URL : https://hal.archives-ouvertes.fr/ineris-00963273
Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system, European Journal of Pharmaceutics and Biopharmaceutics, vol.58, issue.2, pp.265-278, 2004. ,
DOI : 10.1016/j.ejpb.2004.03.001
Preparation of aqueous magnetic liquids in alkaline and acidic media, IEEE Transactions on Magnetics, vol.17, issue.2, pp.1247-1248, 1981. ,
DOI : 10.1109/TMAG.1981.1061188
Preparation of magnetic granules containing bleomycin and its evaluation using model esophageal cancer, International Journal of Pharmaceutics, vol.147, issue.1, pp.119-125, 1997. ,
DOI : 10.1016/S0378-5173(96)04804-1
Gastroretentive drug delivery systems : a review, Asian J. Pharm. Clin. Res, vol.3, issue.1, pp.2-10, 2010. ,
Magnetic targeting for site-specific drug delivery: applications and clinical potential, Expert Opinion on Drug Delivery, vol.32, issue.1, pp.53-70, 2009. ,
DOI : 10.1016/j.biomaterials.2008.07.004
Review of the Gastrointestinal Tract: From Macro to Micro, Seminars in Oncology Nursing, vol.25, issue.1, 2009. ,
DOI : 10.1016/j.soncn.2008.10.002
The use of mucoadhesive polymers in buccal drug delivery, Adv. Drug Deliv. Rev, vol.57, 2005. ,
The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics, Cell Biology and Toxicology, vol.21, issue.1, pp.1-26, 2005. ,
DOI : 10.1007/s10565-005-0085-6
Performance of magnetic chitosan???alginate core???shell beads for increasing the bioavailability of a low permeable drug, European Journal of Pharmaceutics and Biopharmaceutics, vol.88, issue.2, 2014. ,
DOI : 10.1016/j.ejpb.2014.05.017
Release characteristics of chitosan treated alginate beads: I. Sustained release of a macromolecular drug from chitosan treated alginate beads, Journal of Microencapsulation, vol.39, issue.2, pp.195-203, 1999. ,
DOI : 10.1080/026520499289176
Drug delivery to the upper small intestine window using gastroretentive technologies, Current Opinion in Pharmacology, vol.6, issue.5, 2006. ,
DOI : 10.1016/j.coph.2006.04.007
Characterization of muco- and bioadhesive properties of chitosan, PVP, and chitosan/PVP blends and release of amoxicillin from alginate beads coated with chitosan/PVP, Drug Development and Industrial Pharmacy, vol.12, issue.6, pp.408-426, 2011. ,
DOI : 10.1080/03639040500214647
The use of charge-coupled polymeric microparticles and micromagnets for modulating the bioavailability of orally delivered macromolecules, Biomaterials, vol.29, issue.9, pp.1216-1223, 2008. ,
DOI : 10.1016/j.biomaterials.2007.11.018
Bioadhesive microspheres as a controlled drug delivery system, International Journal of Pharmaceutics, vol.255, issue.1-2, pp.13-32, 2003. ,
DOI : 10.1016/S0378-5173(03)00087-5
pH-sensitive magnetic alginate-chitosan beads for albendazole delivery, Pharmaceutical Development and Technology, vol.48, issue.3, pp.228-3610, 2011. ,
DOI : 10.1016/j.mrgentox.2006.09.004
Oral delivery of macromolecules using intestinal patches: applications for insulin delivery, Journal of Controlled Release, vol.98, issue.1, 2004. ,
DOI : 10.1016/j.jconrel.2004.04.013
Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone, International Journal of Pharmaceutics, vol.312, issue.1-2, 2006. ,
DOI : 10.1016/j.ijpharm.2006.01.003
Application of Monodirectional Janus Patch to Oromucosal Delivery System, Advanced Healthcare Materials, vol.38, issue.15, pp.2229-2236, 2015. ,
DOI : 10.1002/adhm.201500416
A magnetic chitosan hydrogel for sustained and prolonged delivery of Bacillus Calmette???Gu??rin in the treatment of bladder cancer, Biomaterials, vol.34, issue.38, pp.10258-66, 2013. ,
DOI : 10.1016/j.biomaterials.2013.09.027